Physiologically-Based Pharmacokinetic Modeling and Bioactivation of Xenobiotics

Abstract

Get full access to this article

View all access options for this article.

References

Adolph, E.F. (1949). "Quantitative relations in the physiological constitutions of mammals." Science 109:579-585.

Andersen, M.E. (1981). "Saturable metabolism and its relation to toxicity." Crit. Rev. Toxicol. 9:105-150.

Andersen, M.E. , Gargas, M.L. , Jones, R.A. , and Jenkins, L.H. JR.. (1980). "Determination of the kinetic constants of metabolism of inhaled toxicant in vivo based on gas uptake measurements." Toxicol. Appl. Pharmacol. 54:100-116.

Andersen, M.E. , Gargas, M.L. , and Ramsey, J.C. (1984a). "Inhalation pharmacokinetics: Evaluating systemic extraction, total in vivo metabolism and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios." Toxicol. Appl. Pharmacol. 73:176-187.

Andersen, M.E. , Archer, R.L. , Clewell, H.J. , and Macnaughton, M.G. (1984b). "A physiological model of the intravenous and inhalation pharmacokinetics of three dihalomethanes — CH2Cl2, CH2BrCl, and CH2Br2 — in the rat." (Abstract 443.) Toxicologist 4(1):111.

Andersen, M.E. , Gargas, M.L. , and Clewell, H.J. (1986a). "Suicide inactivation of microsomal oxidation by cis- and trans-dichloroethylene (C-DCE and T-DCE) in male fischer rats in vivo." (Abstract 47.) Toxicologist 6(1):12.

Andersen, M.E. , Clewell, H.J. , Gargas, M.L. , and Conolly, R.B. (1986b). "A physiological pharmacokinetic model for hepatic glutathione (GSH) depletion by inhaled halogenated hydrocarbons." (Abstract 598.) Toxicologist 6(1):148.

Andersen, M.E. , Clewell, H.J. Gargas, M.L. , Smith, F.A. , and Reitz, R.H. (1987a). "Physiologically-based pharmacokinetics and the risk assessment for methylene chloride." Toxicol. Appl. Pharmacol. 87:185-205.

Andersen, M.E. , Gargas, M.L. , Clewell, H.J. , and Severyn, K.M. (1987b). "Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene by gas uptake methods." Toxicol. Appl. Pharmacol. 89:149-157.

10.

Andersen, M.E. , Clewell, H.J. , III, Gargas, M.L. , Macnaughton, M.G. , Reitz, R.H. , Nolan, R. , and McKenna, M. (1991). "Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite carbon monoxide, and blood carboxyhemoglobin in rats and humans." Toxicol. Appl. Pharmacol. 108:14-27.

11.

Andersen, M.E. , Mills, J.J. , Gargas, M.L. , Kedderis, L. , Birnbaum, L.S. , Norbert, D. , and Greenlee, W.F. (1993). "Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment." Risk Anal. 13(1):25-36.

12.

Bischoff, K.B. (1987)."Physiologically based pharmacokinetic modeling. National Research Council." In: Pharmacokinetics in Risk Assessment. Drinking Water and Health. Volume 8, pp. 36-61. National Academy Press, Washington, DC.

13.

Bischoff, K.B. and Brown, R.G. (1966). "Drug distribution in mammals." Chem. Eng. Prog. Symp. Ser. 62(66):33-45.

14.

Bungay, P.M. , Dedrick, R.L. , and Matthews, H.B. (1981). "Enteric transport of chlordecone (Kepone ) in the rat." J. Pharmacokinet. Biopharm. 9:309-341.

15.

Clewell, H.J. (1993). "Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing." Toxicol. Lett . 68:101-117.

16.

Clewell, H.J. and Andersen, M.E. (1986). "A multiple dose-route physiological pharmacokinetic model for volatile chemicals using ACSL/PC." In: Languages for Continuous System Simulation (F.D. Cellier, ed.). Society for Computer Simulation, San Diego, CA. pp. 95-101.

17.

Clewell, H.J. and Anderson, M.E. (1987). "Dose, species and route extrapolation using physiologically based pharmacokinetic models." In: Pharmacokinetics in Risk Assessment. Drinking Water and Health. Volume 8, National Academy Press, Washington, D.C. pp. 159-182.

18.

Clewell, H.J. and Andersen, M.E. (1989). "Improving toxicology testing protocols using computer simulations." Toxicol. Lett. 49:139-158.

19.

Conolly, R.B. and Andersen, M.E. (1991). "Biologically based pharmacodynamic models: Tools for toxicological research and risk assessment." Comments Toxicol. 4:269-293.

20.

Corley, R.A. , Mendrala, A.L. , Smith, F.A. , Staats, D.A. , Gargas, M.L. , Conolly, R.B. , Andersen, M.E. , and Reitz, R.H. (1990). "Development of a physiologically based pharmacokinetic model for chloroform." Toxicol. Appl. Pharmacol. 103:512-527.

21.

D'Souza, R.W. , Francis, W.R. , and Andersen, M.E. (1988). "Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure." J. Pharmacol. Exper. Ther. 245:563-568.

22.

Dedrick, R.L. (1973). "Animal scale-up." J. Pharmacokinet. Biopharm. 1:435-461.

23.

Dedrick, R.L. and Bischoff, K.B. (1980). "Species similarities in pharmacokinetics." Fed. Proc. 39:54-59.

24.

Filser, J.G. and Bolt, H.M. (1979). "Pharmacokinetics of halogenated ethylenes in rats." Arch. Toxicol. 42:123-136.

25.

Fisher, J.W. , Whittaker, T.A. , Taylor, D.H. , Clewell, H.J. , and Andersen, M.E. (1989). "Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichlorethylene and its metabolite, trichloroacetic acid." Toxicol. Appl. Pharmacol . 99:395-414.

26.

Fisher, J.W. , Whittaker, T.A. , Taylor, D.H. , Clewell, H.J. , and Andersen, M.E. (1990). "Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichlorethylene and its metabolite, trichloroacetic acid." Toxicol. Appl. Pharmacol. 102:497-513.

27.

Gargas, M.L. (1990). "An exhaled breath chamber system for assessing rates of metabolism and rates of gastrointestinal absorption with volatile chemicals." J. Am. Coll. Toxicol. 9:447-453.

28.

Gargas, M.L. and Andersen, M.E. (1982). "Metabolism of inhaled brominated hydrocarbons: validation of gas uptake results by determination of a stable metabolite." Toxicol. Appl. Pharmacol. 66:55-68.

29.

Gargas, M.L. and Andersen, M.E. (1989). "Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation." Toxicol. Appl. Pharmacol. 97:230-246.

30.

Gargas, M.L. , Andersen, M.E. , and Clewell, H.J. (1986a). "A physiologically-based simulation approach for determining metabolic constants from gas uptake data." Toxicol. Appl. Pharmacol. 86:341-352.

31.

Gargas, M.L. , Clewell, H.J. , and Andersen, M.E. (1986b). "Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathways." Toxicol. Appl. Pharmacol. 82:211-223.

32.

Gearhart, J.M. , Jepson, G.W. , Clewell, H.J. , Andersen, M.E. , and Conolly, R.B. (1990). "Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate." Toxicol. Appl. Pharmacol. 106:295-310.

33.

Gerlowski, L.E. and Jain, R.K. (1983). "Physiologically based pharmacokinetic modeling: Principles and applications." J. Pharm. Sci. 72:1103-1126.

34.

Himmelstein, K.J. and Lutz, R.J. (1979). "A review of the application of physiologically based pharmacokinetic modeling." J. Pharmacokinet. Biopharm . 7:127-145.

35.

King, F.G. , Dedrick, R.L. , Collins, J.M. , Matthews, H.B. , and Birnbaum, L.S. (1983). "Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species." Toxicol. Appl. Pharmacol. 67:390-400.

36.

Leung, H.W. (1991). "Development and utilization of physiologically based pharmacokinetic models for toxicological applications." J. Toxicol. Environ. Health 32:247-267.

37.

Leung, H.W. , Ku, R.H. , Paustenbach, D.J. , and Andersen, M.E. (1988). "A physiologically-based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice." Toxicol. Lett. 42:15-28.

38.

Lutz, R.J. , Dedrick, R.L. , Tuey, D. , Sipes, I.G. , Anderson, M.W. , and Matthews, H.B. (1984). "Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model." Drug Metab. Disp. 12:5:527-535.

39.

Mc Dougal, J.N. , Jepson, G.W. , Clewell, H.J. , Macnaughton, M.G. , and Andersen, M.E. (1986). "A physiological pharmacokinetic model for dermal absorption of vapors in the rat." Toxicol. Appl. Pharmacol . 85:286-294.

40.

Monro, A. (1992). "What is an appropriate measure of exposure when testing drugs for carcinogenicity in rodents?" Toxicol. Appl. Pharmacol. 112:171-181.

41.

O'Flaherty, E.J. (1987). "Modeling: an introduction. National Research Council." In: Pharmacokinetics in Risk Assessment. Drinking Water and Health, Volume 8. National Academy Press, Washington, DC. pp. 27-35.

42.

Paustenbach, D.J. , Clewell, H.J. , Gargas, M.L. , and Andersen, M.E. (1988). "A physiologically-based pharmacokinetic model for inhaled carbon tetrachloride." Toxicol. Appl. Pharmacol . 96:191-211.

43.

Ramsey, J.C. and Andersen, M.E. (1984). "A physiological model for the inhalation pharmacokinetics of inhaled styrene monomer in rats and humans." Toxicol. Appl. Pharmacol. 73:159-175.

44.

Ramsey, J.C. and Young, J.D. (1978). "Pharmacokinetics of inhaled styrene in rats and humans." Scand. J. Work Environ. Health 4:84-91.

45.

Ramsey, J.C. , Young, J.D. , Karbowski, R. , Chenoweth, M.B, Mc Carty, L.P. , and Braun, W.H. (1980). "Pharmacokinetics of inhaled styrene in human volunteers." Toxicol. Appl. Pharmacol . 53:54-63.

46.

Reitz, R.H. , Mendrala, A.L. , and Guengerich, F.P. (1989). "In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically-based pharmacokinetic models." Toxicol. Appl Pharmacol. 97:230-246.

47.

Sato, A. and Nakajima, T. (1979a). "Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil." Br. J. Ind. Med. 36:231-234.

48.

Sato, A. and Nakajima, T. (1979b). "A vial equilibration method to evaluate the drug metabolizing enzyme activity for volatile hydrocarbons." Toxicol. Appl. Pharmacol. 47:41-46.

49.

Stewart, R.D. , Dodd, H.C. , Baretta, E.D. , and Schaffer, A.W. (1968). "Human exposure to styrene vapors." Arch. Env. Health. 16:656-662.

50.

Teorell, T. (1937a). "Kinetics of distribution of substances administered to the body. I. The extravascular mode of administration." Arch. Int. Pharmacodyn. 57:205-225.

51.

Teorell, T. (1937b). "Kinetics of distribution of substances administered to the body. I. The intravascular mode of administration." Arch. Int. Pharmacodyn. 57:226-240.

52.

Tuey, D.B. and Matthews, H.B. (1980). "Distribution and excretion of 2,2',4,4',5,5'-hexabromobiphenyl in rats and man: Pharmacokinetic model predictions." Toxicol. Appl. Pharmacol. 53:420-431.

53.

Vinegar, A. , Seckel, C.S. , Pollard, D.L. , Kinkead, E.R. , Conolly, R.B. , and Andersen, M.E. (1992). "Polychlorotrifluoroethylene (PCTFE) oligomer pharmacokinetics in Fischer 344 rats: Development of a physiologically based model." Fundam. Appl. Toxicol. 18:504-514.

54.

Watanabe P. , Mc Gown, G. , and Gehring, P. (1976). "Fate of [14] vinyl chloride after single oral administration in rats." Toxicol Appl Pharmacol 36:339-352.